HFpEF vs. HFrEF: How To Improve Heart Failure Drug Development
XTalks
APRIL 15, 2021
Late-stage clinical trial failures are largely to blame for the lack of effective treatment options for patients with HFpEF, and poor five-year survival rates make this an area of great unmet need. Since it’s not always possible to measure the direct effect of a gene, biomarkers are often used to measure its effect on a given outcome. “If
98 
Let's personalize your content